AstraZeneca ‘committed’ to US manufacturing as pro... Financial Times

AstraZeneca ‘committed’ to US manufacturing as profits rise

Financial Times April 29, 2025

Anglo-Swedish pharma company’s first-quarter earnings boosted by strong demand for cancer drugs

Comments 0

Log in to post a comment.

No comments yet. Be the first to comment!

Source Information
Financial Times

Published on April 29, 2025

Visit Source
Advertise with Us

Reach our audience with your ads